Pain syndromes in cancer survivors

Cancer Pain: Assessment and Management, Second Edition

Volumn , Issue , 2009, Pages 145-164

  Polomano, Rosemary C ^a   Ashburn, Michael ^a   Farrar, John T ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879177244     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511642357.009     Document Type: Chapter

References (167)

1. American Cancer Society. Cancer facts and figures 2007. Atlanta: American Cancer Society, 2007. Available at: http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf. Accessed November 12, 2007.
2. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, CA Cancer J Clin 47:5-27, 1997.
3. Edwards BK, Howe HL, Ries LA, et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 94:2766-92, 2002.
4. Rowland J, Mariotto A, Aziz N, et al. Cancer survivorship - United States, 1971-2001. MMWR Morb Mortal Wkly Rep 53:526-9, 2004.
5. Travis LB, Rabkin CS, Brown LM, et al. Cancer survivorship - genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst 98:15-25, 2006.
6. Polomano RC, Farrar JT. Pain and neuropathy in cancer survivors. Surgery, radiation, and chemotherapy can cause pain; research could improve its detection and treatment. Am J Nurs 106(3 Suppl):39-47, 2006.
7. Institute of Medicine of the National Academies. Implementing cancer survivorship care planning: workshop summary. Available at: http://www.iom.edu/CMS/26765/39416.aspx. Accessed November 14, 2007.
8. Institute of Medicine of the National Academies. From cancer to cancer survivor: lost in transition. Institute of Medicine of the National Academies report, November 7, 2005. Available at: http://www.iom.edu/CMS/28312/4931/30869.aspx. Accessed November 14, 2007.
9. National Cancer Institute. Dictionary of cancer terms; survivorship. Available at: http://www.cancer.gov/Templates/db_alpha.aspx?CdrID=445089. Accessed November 14, 2007.
10. Mao JJ, Armstrong K, Bowman MA, et al. Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med 20:434-43, 2007.
11. Keating NL, Norredam M, Landrum MB, et al. Physical and mental health status of older long-term cancer survivors. J Am Geriatr Soc 53:2145-52, 2005.
12. Mols F, Coebergh JW, van de Poll-Franse LV. Health-related quality of life and health care utilisation among older longterm cancer survivors: a population-based study. Eur J Cancer 43:2211-21, 2007.
13. Foley KL, Farmer DF, Petronis VM, et al. A qualitative exploration of the cancer experience among long-term survivors: comparisons by cancer type, ethnicity, gender, and age. Psychooncology 15:248-58, 2006.
14. Tasmuth T, Kataja M, Blomqvist C, et al. Treatment-related factors predisposing to chronic pain in patients with breast cancer - a multivariate approach. Acta Oncol 36:625-30, 1997.
15. Tasmuth T, Blomqvist C, Kalso E. Chronic post-treatment symptoms in patients with breast cancer operated in different surgical units. Eur J Surg Oncol 25:38-43, 1999.
16. Perttunen K, Tasmuth T, Kalso E. Chronic pain after thoracic surgery: a follow-up study. Acta Anaesthesiol Scand 43:563-7, 1999.
17. Karmakar MK, Ho AM. Postthoracotomy pain syndrome. Thorac Surg Clin 14:345-52, 2004.
18. Gotoda Y, Kambara N, Sakai T. The morbidity, time course and predictive factors for persistent post-thoracotomy pain. Eur J Pain 5:89-96, 2001.
19. Rauch P, Miny J, Conroy T, et al. Quality of life among disease-free survivors of rectal cancer. J Clin Oncol 22:354-60, 2004.
20. Marchettini P, Formaglio F, Lacerenza M. Iatrogenic painful neuropathic complications of surgery in cancer. Acta Anaes- thesiol Scand 45:1090-4, 2001.
21. Perkins FM, Kehlet H. Chronic pain as an outcome of surgery. a review of predictive factors. Anesthesiology 93:1123-33, 2000.
22. Polomano RC, Bennett GJ. Chemotherapy-evoked painful peripheral neuropathy. Pain Med 2:8-14, 2001.
23. Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol 249:9-17, 2002.
24. Dropcho EJ. Neurotoxicity of cancer chemotherapy. Semin Neurol 24:419-26, 2004.
25. Azinovic I, Calvo FA, Puebla F, et al. Long-term normal tissue effects of intraoperative electron radiation therapy (IOERT): late sequelae, tumor recurrence, and second malignancies. Int J Radiat Oncol Biol Phys 49:597-604, 2001.
26. Rubin DI, Schomberg PJ, Shepherd RF, Panneton JM. Arteritis and brachial plexus neuropathy as delayed complications of radiation therapy. Mayo Clin Proc 76:849-52, 2001.
27. Schierle C, Winograd JM. Radiation-induced brachial plex- opathy: review. Complication without a cure. J Reconstr Microsurg 20:149-52, 2004.
28. Vargas C, Martinez A, Kestin LL, et al. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Int J Radiat Oncol Biol Phys 62:1297-308, 2005.
29. Wilson SA, Rex DK. Endoscopic treatment of chronic radiation proctopathy. Curr Opin Gastroenterol 22:536-40, 2006.
30. Sandel HD 4th, Davison SP. Microsurgical reconstruction for radiation necrosis: an evolving disease. J Reconstr Microsurg 23:225-30, 2007.
31. Hoff AO, Gagel RF. Osteoporosis in breast and prostate cancer survivors. Oncology (Williston Park) 19:651-8, 2005.
32. Karimova EJ, Rai SN, Howard SC, et al. Femoral head osteonecrosis in pediatric and young adult patients with leukemia or lymphoma. J Clin Oncol 20:25; 1525-31, 2007.
33. Merskey H, Bogduk N, eds. International Association for the Study of Pain. Task Force on Taxonomy. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms, 2nd ed. Seattle: IASP Press, 1994.
34. Lyne ME, Coyne PJ, Watson AC. Pain management issues for cancer survivors. Cancer Pract 10(Suppl 1): S27-32, 2002.
35. Portenoy RK, Conn M. Cancer pain syndromes. In: Cancer pain: assessment and management. New York: Cambridge University Press, 2003, pp 89-110.
36. van Wilgen CP, Dijkstra PU, Van Der Laan BF, et al. Morbidity of the neck after head and neck cancer therapy. Head Neck 26:785-91, 2004.
37. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet 367:1618-25, 2006.
38. Kline DG, Hudson AR. Nerve injuries. Philadelphia: WB Saunders Company, 1995.
39. Carr DB, Goudas LC. Acute pain. Lancet 353:2051-8, 1999.
40. Wilsey B, Teicheira D, Caneris OA, Fishman SM. A review of sympathetically maintained pain syndromes in the cancer pain population: the spectrum of ambiguous entities of RSD, CRPS, SMP and other pain states related to the sympathetic nervous system. Pain Pract 1:307-23, 2001.
41. McCormack K, Wake B, Perez J, et al. Laparoscopic surgery for inguinal hernia repair: systematic review of effectiveness and economic evaluation. Health Technol Assess 9:1-203, 2005.
42. Fassoulaki A, Triga A, Melemeni A, Sarantopoulos C. Multimodal analgesia with gabapentin and local anesthetics prevents acute and chronic pain after breast surgery for cancer. Anesth Analg 101:1427-32, 2005.
43. White PF. Multimodal analgesia: its role in preventing postoperative pain. Curr Opin Investig Drugs 9:76-82, 2008.
44. Marhofer P, Chan VW. Ultrasound-guided regional anesthesia: current concepts and future trends. Anesth Analg 104:1265-9, 2007.
45. Savage C, McQuitty C, Wang D, Zwischenberger JB. Postthoracotomy pain management. Chest Surg Clin N Am 12:25163, 2002.
46. Gendall KA, Kennedy RR, Watson AJ, Frizelle FA. The effect of epidural analgesia on postoperative outcome after colorectal surgery. Colorectal Dis 9:584-98, 2007.
47. Marret E, Remy C, Bonnet F; Postoperative Pain Forum Group. Meta-analysis of epidural analgesia versus parenteral opioid analgesia after colorectal surgery. Br J Surg 94:665-73, 2007.
48. Elia N, Lysakowski C, Tramer MR. Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient- controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials. Anesthesiology 103:1296-1304, 2005.
49. Straube S, Derry S, McQuay HJ, Moore RA. Effect of preoperative Cox-II-selective NSAIDs (coxibs) on postoperative outcomes: a systematic review of randomized studies. Acta Anaesthesiol Scand 49:601-13, 2005.
50. Schell SR. Patient outcomes after axillary lymph node dissection for breast cancer: use of postoperative continuous local anesthesia infusion. J Surg Res 134:124-32, 2006.
51. Beaussier M, El’Ayoubi H, Schiffer E, et al. Continuous preperitoneal infusion of ropivacaine provides effective analgesia and accelerates recovery after colorectal surgery: a randomized, double-blind, placebo-controlled study. Anesthesiology 107:461-8, 2007.
52. Liu SS, Richman JM, Thirlby RC, Wu CL. Efficacy of continuous wound catheters delivering local anesthetic for postoperative analgesia: a quantitative and qualitative systematic review of randomized controlled trials. J Am Coll Surg 203:914-32, 2006.
53. Tiippana EM, Hamunen K, Kontinen VK, Kalso E. Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety. Anesth Analg 104:1545-56, 2007.
54. Ho KY, Gan TJ, Habib AS. Gabapentin and postoperative pain - a systematic review of randomized controlled trials. Pain 126(1-3):91-101, 2006.
55. Ververs JM, Roumen RM, Vingerhoets AJ, et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 37:991-9, 2001.
56. Carpenter JS, Sloan P, Andrykowski MA, et al. Risk factors for pain after mastectomy/lumpectomy. Cancer Pract 7:66-70, 1999.
57. Carpenter JS, Andrykowski MA, Sloan P, et al. Postmastec- tomy/postlumpectomy pain in breast cancer survivors. J Clin Epidemiol 51:1285-92, 1998.
58. Bosompra K, Ashikaga T, O’Brien PJ, et al. Swelling, numbness, pain, and their relationship to arm function among breast cancer survivors: a disablement process model perspective. BreastJ 8:338-48, 2002.
59. Stevens PE, Dibble SL, Miaskowski C. Prevalence, characteristics, and impact of postmastectomy pain syndrome: an investigation of women’s experiences. Pain 61:61-8, 1995.
60. Macdonald L, Bruce J, Scott NW, et al. Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer 92:225-30, 2005.
61. Miguel R, Kuhn AM, Shons AR, et al. The effect of sentinel node selective axillary lymphadenectomy on the incidence of postmastectomy pain syndrome. Cancer Control 8:427-30, 2001.
62. Eversley R, Estrin D, Dibble S, et al. Post-treatment symptoms among ethnic minority breast cancer survivors. Oncol Nurs Forum 32:250-6, 2005.
63. Hurley RW, Cohen SP, Williams KA, et al. The analgesic effects of perioperative gabapentin on postoperative pain: a meta-analysis. Reg Anesth Pain Med 31:237-47, 2006.
64. Eisenberg E, Pud D, Koltun L, Loven D. Effect of early administration of the N-methyl-d-aspartate receptor antagonist amantadine on the development of postmastectomy pain syndrome: a prospective pilot study. J Pain 8:223-9, 2007.
65. Hautkappe M, Roizen MF, Toledano A, et al. Review of the effectiveness of capsaicin for painful cutaneous disorders and neural dysfunction. Clin J Pain 14:97-106, 1998.
66. Dajczman E, Gordon A, Kreisman H, Wolkove N. Long-term postthoracotomy pain. Chest 99:270-4, 1991.
67. Erdek MA, Staats PS. Chronic pain and thoracic surgery. Tho- rac Surg Clin 15:123-30, 2005.
68. Gotoda Y, Kambara N, Sakai T, et al. The morbidity, time course and predictive factors for persistent post-thoracotomy pain. Eur J Pain 5:89-96, 2001.
69. Senturk M, Ozcan PE, Talu GK, et al. The effects of three different analgesia techniques on long-term postthoracotomy pain. Anesth Analg 94:11-15, 2002.
70. Pourel N, Peiffert D, Lartigau E, et al. Quality of life in longterm survivors of oropharynx carcinoma. Int J Radiat Oncol Biol Phys 54:742-51, 2002.
71. Remmler D, Byers R, Scheetz J, et al. A prospective study of shoulder disability resulting from radical and modified neck dissections. Head Neck Surg 8:280-6, 1986.
72. Chua KS, Reddy SK, Lee MC, Patt RB. Pain and loss of function in head and neck cancer survivors. J Pain Symptom Manage 18:193-202, 1999.
73. Vecht CJ, Hoff AM, Kansen PJ, et al. Types and causes of pain in cancer of the head and neck. Cancer 70:178-84, 1992.
74. Grond S, Zech D, Lynch J, et al. Validation of World Health Organization guidelines for pain relief in head and neck cancer: a prospective study. Ann Otol Rhinol Laryngol 102:3428, 1993.
75. Talmi YP, Horowitz Z, Pfeffer MR, et al. Pain in the neck after neck dissection. Otolaryngol Head Neck Surg 123:302-6, 2000.
76. Wittekindt C, Liu WC, Preuss SF, Guntinas-Lichius O. Botulinum toxin A for neuropathic pain after neck dissection: adose-finding study. Laryngoscope 116:1168-71, 2006.
77. Courneya KS, Seikaly H, Jha N, et al. A pilot study of a randomized controlled trial to evaluate the effects of progressive resistance exercise training on shoulder dysfunction caused by spinal accessory neurapraxia/neurectomy in head and neck cancer survivors. Head Neck 26:518-30, 2004.
78. Flor H. Phantom-limb pain: characteristics, causes, and treatment. Lancet Neurol 1:182-9, 2002.
79. Elzinga A, Van Der Schans CP. Phantom pain and phantom sensations in upper limb amputees: an epidemiological study. Pain 87:33-41, 2000.
80. Jensen TS, Nikolajsen L. Phantom pain and other phenomena after amputation. In: Wall PD, Melzack RA, eds. Textbook of pain, 4th ed. Edinburgh: Churchill Livingstone, 1999, pp 799-814.
81. Burton AW, Fanciullo GJ, Beasley RD, Fisch MJ. Chronic pain in the cancer survivor: a new frontier. Pain Med 8:189-98, 2007.
82. Ben Abraham R, Marouani N, Kollender Y, et al. Dextromethorphan for phantom pain attenuation in cancer amputees: a double-blind crossover trial involving three patients. Clin J Pain 18:282-5, 2002.
83. Ben Abraham R, Marouani N, Weinbroum AA. Dextromethorphan mitigates phantom pain in cancer amputees. Ann Surg Oncol 10:268-74, 2003.
84. Sakorafas GH, Peros G, Cataliotti L, Vlastos G. Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 15:153-65, 2006.
85. Meneses KD, McNees MP. Upper extremity lymphedema after treatment for breast cancer: a review of the literature. Ostomy Wound Manage 53:16-29, 2007.
86. Beesley V, Janda M, Eakin E, et al. Lymphedema after gynecological cancer treatment: prevalence, correlates, and supportive care needs. Cancer 109:2607-14, 2007.
87. Lockwood-Rayermann S. Lymphedema in gynecologic cancer survivors: an area for exploration? Cancer Nurs 30: E11-8, 2007.
88. Okeke AA, Bates DO, GillattDA. Lymphoedema in urological cancer. Eur Urol 45:18-25, 2004.
89. Erickson VS, Pearson ML, Ganz PA, et al. Arm edema in breast cancer patients. J Natl Cancer Inst 93:96-111, 2001.
90. Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 92:1368-77, 2001.
91. Morrell RM, Halyard MY, Schild SE, et al. Breast cancer- related lymphedema. Mayo Clin Proc 80:1480-4, 2005.
92. Lane K, Worsley D, McKenzie D. Exercise and the lymphatic system: implications for breast-cancer survivors. Sports Med 35:461-71, 2005.
93. Moseley AL, Carati CJ, Piller NB. A systematic review of common conservative therapies for arm lymphoedema secondary to breast cancer treatment. Ann Oncol 18:639-46, 2007.
94. Golshan M, Smith B. Prevention and management of arm lymphedema in the patient with breast cancer. J Support Oncol 4:381-6, 2006.
95. Bucci MK, Bevan A, Roach M 3rd. Advances in radiation therapy: conventional to 3D, to IMRT, to 4D, and beyond. CA Cancer J Clin 55:117-34, 2005.
96. Gordils-Perez J, Rawlins-Duell R, Kelvin JF. Advances in radiation treatment of patients with breast cancer. Clin J Oncol Nurs 7:629-36, 2003.
97. Johansson S, Svensson H, Denekamp J. Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Biol Phys 48:74550, 2000.
98. McFarlane VJ, Clein GP, Cole J, et al. Cervical neuropathy following mantle radiotherapy. Clin Oncol (R Coll Radiol) 14:468-71, 2002.
99. Becker M, Schroth G, Zbaren P, et al. Long-term changes induced by high-dose irradiation of the head and neck region: imaging findings. Radiographics 17:5-26, 1997.
100. Maddison P, Southern P, Johnson M. Clinical and MRI discordance in a case of delayed radiation myelopathy. J Neurol Neurosurg Psychiatry 69:563-4, 2000.
101. Chan L, Yeo W, Leung SF, et al. Delayed radiation myelopathy after concurrent chemoradiation for hypopharyngeal- esophageal carcinoma. Acta Oncol 44:177-9, 2005.
102. Bye A, Trope C, Loge JH, et al. Health-related quality of life and occurrence of intestinal side effects after pelvic radiotherapy-evaluation of long-term effects of diagnosis and treatment. Acta Oncol 39:173-80, 2000.
103. Vanagunas A. Radiation-induced gastrointestinal disease. Clin Perspect Gastroenterol March/April:69-75, 2001.
104. Regimbeau JM, Panis Y, Gouzi JL, et al. Operative and long term results after surgery for chronic radiation enteritis. Am J Surg 182:237-42, 2001.
105. Miller AR, Martenson JA, Nelson H, et al. The incidence and clinical consequences of treatment-related bowel injury. Int J Radiat Oncol Biol Phys 43:817-25, 1999.
106. Marshall GT, Thirlby RC, Bredfeldt JE, Hampson NB. Treatment of gastrointestinal radiation injury with hyperbaric oxygen. Undersea Hyperb Med 34:35-42, 2007.
107. Mann WJ. Surgical management of radiation enteropathy. Surg Clin North Am 71:977-90, 1991.
108. Jain G, Scolapio J, Wasserman E, Floch MH. Chronic radiation enteritis: a ten-year follow-up. J Clin Gastroenterol 35:214-17, 2002.
109. Ajlouni M. Radiation-induced proctitis. Curr Treat Options Gastroenterol 2:20-6, 1999.
110. Otchy DP, Nelson H. Radiation injuries of the colon and rectum. Surg Clin North Am 73:1017-35, 1993.
111. Wilson SA, Rex DK. Endoscopic treatment of chronic radiation proctopathy. Curr Opin Gastroenterol 22:536-40, 2006.
112. Tagkalidis PP, Tjandra JJ. Chronic radiation proctitis. ANZ J Surg 71:230-7, 2001.
113. Colwell JC, Goldberg M. A review of radiation proctitis in the treatment of prostate cancer. J Wound Ostomy Continence Nurs 27:179-87, 2000.
114. Dall’Era MA, Hampson NB, Hsi RA, et al. Hyperbaric oxygen therapy for radiation induced proctopathy in men treated for prostate cancer. J Urol 176:87-90, 2006.
115. Konishi T, Watanabe T, Nagawa H. Formalin application in the treatment of chronic radiation-induced hemorrhagic proctitis induces acute deterioration of mucosal blood flow. Dis Colon Rectum 49:530-1, 2006.
116. Chapuis P, Dent O, Bokey E, et al. The development of a treatment protocol for patients with chronic radiation-induced rectal bleeding. Aust N Z J Surg 66:680-5, 1996.
117. Tjandra JJ, Sengupta S. Argon plasma coagulation is an effective treatment for refractory hemorrhagic radiation proctitis. Dis Colon Rectum 44:1759-65, 2001.
118. Bartleson JD, Krecke KN, O’Neill BP, Brown PD. Reversible, strokelike migraine attacks in patients with previous radiation therapy. Neuro Oncol 5:121-7, 2003.
119. Pruitt A, Dalmau J, Detre J, et al. Episodic neurologic dysfunction with migraine and reversible imaging findings after radiation. Neurology 67:676-8, 2006.
120. Cordato DJ, Brimage P, Masters LT, Butler P. Post-cranial irradiation syndrome with migraine-like headaches, prolonged and reversible neurological deficits and seizures. J Clin Neurosci 13:586-90, 2006.
121. Partap S, Walker M, Longstreth WT Jr, Spence AM. Prolonged but reversible migraine-like episodes long after cranial irradiation. Neurology 66:1105-7, 2006.
122. Aley KO, et al. Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans. Neuroscience 73:259-65, 1996.
123. Boyle FM, et al. Amelioration of experimental cisplatin and paclitaxel neuropathy with glutamate. J Neurooncol 41:10716, 1999.
124. Polomano RC, et al. A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain 94:293-304, 2001.
125. Dougherty PM, Cata JP, Cordella JV, e al. Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 109:132-42, 2004.
126. Koros C, Papalexi E, Anastasopoulos D, et al. Effects of AraC treatment on motor coordination and cerebellar cytoarchitec- ture in the adult rat. A possible protective role of NAC. Neurotoxicology 28:83-92, 2007.
127. Visovsky C. Chemotherapy-induced peripheral neuropathy. Cancer Invest 21:439-51, 2003.
128. Kannarkat G, Lasher EE, Schiff D. Neurologic complications of chemotherapy agents. Curr Opin Neurol 20:719-25, 2007.
129. Verstappen CC, Heimans JJ, Hoekman K, Postma TJ. Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 63:1549-63, 2003.
130. Argyriou AA, Polychronopoulos P, Koutras A, et al. Is advanced age associated with increased incidence and severity of chemotherapy-induced peripheral neuropathy? Support Care Cancer 14:223-9, 2006.
131. Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol 249:9-17, 2002.
132. LoMonaco M, Milone M, Batocchi AP, et al. Cisplatin neuropathy: clinical course and neurophysiological findings. J Neurol 239:199-204, 1992.
133. Strumberg D, Brugge S, Korn MW, et al. Evaluation of longterm toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer. Ann Oncol 13:229-36, 2002.
134. Fossa SD. Long-term sequelae after cancer therapy - survivorship after treatment for testicular cancer. Acta Oncol 43:13441, 2004.
135. Oldenburg J, Fossa SD, Dahl AA. Scale for chemotherapy- induced long-term neurotoxicity (SCIN): psychometrics, validation, and findings in a large sample of testicular cancer survivors. Qual Life Res 15:791-800, 2006.
136. Moser EC, Noordijk EM, Carde P, et al. Late non-neoplastic events in patients with aggressive non-Hodgkin’s lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials. Clin Lymphoma Myeloma 6:122-30, 2005.
137. Oshita F, Tamura T, Kojima A, et al. Late toxicities and complications in three-year survivors of small cell lung cancer. Eur J Cancer 27:427-30, 1991.
138. Benedetti Panici P, Greggi S, Scambia G, et al. Efficacy and toxicity of very high-dose cisplatin in advanced ovarian carcinoma: 4-year survival analysis and neurological follow-up. IntJ Gynecol Cancer 3:44-53, 1993.
139. Cavaletti G, Zanna C. Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity. Eur J Cancer 38:1832-7, 2002.
140. Savarese DM, Savy G, Vahdat L, et al. Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev 29:501-13, 2003.
141. Argyriou AA, Chroni E, Koutras A, et al. Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial. Neurology 64:26-31, 2005.
142. Cata JP, Cordella JV, Burton AW, et al. Spinal cord stimulation relieves chemotherapy-induced pain: a clinical case report. J Pain Symptom Manage 27:72-8, 2004.
143. Rock E, De Michele A. Nutritional approaches to late toxicities of adjuvant chemotherapy in breast cancer survivors. J Nutr 133(11 Suppl 1):3785S-93S, 2003.
144. Baker KS, Gurney JG, Ness KK, et al. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. Blood 104:1898-906, 2004.
145. Majhail NS, Ness KK, Burns LJ, et al. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biol Blood Marrow Transplant 13:1153-9, 2007.
146. Rugo HS. Strategies for the prevention of treatment-related bone loss in women receiving adjuvant hormonal therapy. Clin Breast Cancer 7(Suppl 1): S21-8, 2007.
147. Reeves KW, Faulkner K, Modugno F, et al. Study of Osteoporotic Fractures Research Group. Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic Fractures. Cancer Epidemiol Biomarkers Prev 16:1468-73, 2007.
148. Brown JE, Ellis SP, Silcocks P, et al. Effect of chemotherapy on skeletal health in male survivors from testicular cancer and lymphoma. Clin Cancer Res 12:6480-6, 2006.
149. Chen AC, Petrylak DP. Complications of androgen- deprivation therapy in men with prostate cancer. Curr Urol Rep 6:210-16, 2005.
150. Limburg CE. Screening, prevention, detection, and treatment of cancer therapy-induced bone loss in patients with breast cancer. Oncol Nurs Forum 34:55-63, 2007.
151. Molina JR, Barton DL, Loprinzi CL. Chemotherapy-induced ovarian failure: manifestations and management. Drug Saf 28:401-16, 2005.
152. Schultz PN, Beck ML, Stava C, et al. Health profiles in 5836 long-term cancer survivors. Int J Cancer 104:488-95, 2003.
153. Tauchmanova L, De Rosa G, Serio B, et al. Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review. Cancer 97:2453-61, 2003.
154. Greenspan SL, Bhattacharya RK, Sereika SM, et al. Prevention of bone loss in survivors of breast cancer: a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab 92:131-6, 2007.
155. Theriault RL, Biermann JS, Brown E, et al. NCCN Task Force report: bone health and cancer care. J Natl Compr Canc Netw 4(Suppl 2): S1-20, 2006.
156. Johnson RW, Whitton TL. Management of herpes zoster (shingles) and postherpetic neuralgia. Expert Opin Pharmacother 5:551-9, 2004.
157. Gordon DB, Love G. Pharmacological management of neuropathic pain. Pain Manag Nurs 5(Suppl 1):19-33, 2005.
158. Dworkin RH, O’Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132:237-51, 2007.
159. Almadrones L, McGuire DB, Walczak JR, et al. Psychometric evaluation of two scales assessing functional status and peripheral neuropathy associated with chemotherapy for ovarian cancer: a gynecologic oncology group study. Oncol Nurs Forum 31:615-23, 2004.
160. Visovsky C, Daly BJ. Clinical evaluation and patterns of chemotherapy-induced peripheral neuropathy. J Am Acad Nurse Pract 16:353-9, 2004.
161. Gruener D, Lande S, eds. Pain control in the primary care setting. Glenview, IL: American Pain Society, 2006.
162. Armstrong T, Almadrones L, Gilbert MR. Chemotherapy- induced peripheral neuropathy. Oncol Nurs Forum 32:305-11, 2005.
163. Arnstein P. Chronic neuropathic pain: issues in patient education. Pain Manag Nurs 5(4 Suppl 1):34-41, 2004.
164. Tesauro GM, Rowland JH, Lustig C. Survivorship resources for post-treatment cancer survivors. Cancer Pract 10:277-83, 2002.
165. Polomano RC, Droog NM, Purinton MCP, Cohen AS. Can social support be found on the World Wide Web?: an evaluation of resources for patients with chronic pain. J Pain Palliat Care Pharmacother 21:49-55, 2007.
166. Panchal SJ, et al. Adult cancer pain. Jenkintown, PA: National Comprehensive Cancer Network, 2005. (Clinical practice guidelines in oncology, v.2.2005). Available at: http://www.nccn.org/professionals/physician_gls/PDF/pain.pdf.
167. Carr DB, Goudas LC, Balk EM, et al. Evidence report on the treatment of pain in cancer patients. J Natl Cancer Inst Monogr (32):23-31, 2004.